arrow
A

Antoni Soriano-Arandes

universidad de los andes (colombia)
H指数:30
被引数:4,089

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Rifampicin-resistant tuberculosis in Spain

利福平耐药结核病在西班牙

2026-02-230
PRE
Real-world impact of nirsevimab immunisation and maternal RSV vaccination against respiratory disease on emergency department attendances and admissions: a multinational retrospective analysis

nirsevimab免疫接种和孕产妇RSV疫苗接种对呼吸系统疾病对急诊科就诊和入院的现实影响: 一项跨国回顾性分析

2026-02-030
OAAI
Both Corticosteroids and Intravenous Immunoglobulin Protect From Aneurysms in Children With Multisystem Inflammatory Syndrome: A Multicenter Ambispective Study

皮质类固醇和静脉免疫球蛋白可保护多系统炎症综合征患儿的血管瘤:一项多中心双向回顾性研究

2025-12-011
PRE
The value of primary care networks for molecular surveillance of paediatric respiratory infections

初级护理网络在儿童呼吸道感染分子监测中的价值

2025-11-290
OAAI
Decline in pediatric respiratory syncytial virus hospitalizations following nirsevimab implementation: a multicenter, three-season observational study

实施 Nirsevimab 后儿科呼吸道合胞病毒住院率的下降:一项多中心、三季度的观察性研究

2025-11-010
OAAI
Impact of nirsevimab immunoprophylaxis on respiratory syncytial virus-related outcomes in hospital and primary care after two consecutive seasons: a population-based retrospective cohort study in infants in their second year of life in Catalonia, Spain

在西班牙加泰罗尼亚地区,对处于第二年生命阶段的婴儿进行的基于人群的回顾性队列研究:评估尼塞维马单抗免疫预防对两个连续流行季后,在医院和初级保健中呼吸道合胞病毒相关结局的影响

2025-09-130
PRE
Evolutionary dynamics of HRSV following the implementation of nirsevimab immunoprophylaxis in Catalonia (2023-2024)

西班牙加泰罗尼亚地区实施nirsevimab免疫预防后HRSV的进化动态(2023-2024)

2025-08-050
OAAI
Real-world impact of nirsevimab immunisation against respiratory disease on emergency department attendances and admissions among infants: a multinational retrospective analysis

奈瑟菌属疫苗免疫对呼吸道疾病急诊就诊和住院率影响的现实世界研究:一项多国回顾性分析

2025-06-030
OA
Phenotypic Variation in Disease Severity Among Hospitalized Pediatric Patients With COVID-19: Assessing the Impact of COVID-19 in the EPICO Study (vol 70, 1607246, 2025)

COVID-19住院儿科患者中疾病严重程度的表型变异:评估EPICO研究(第70卷,1607246,2025)中COVID-19的影响

2025-04-220
OA
Introduction of nirsevimab in Catalonia, Spain: description of the incidence of bronchiolitis and respiratory syncytial virus in the 2023/2024 season

在西班牙加泰罗尼亚引入nirsevimab: 2023/2024季节毛细支气管炎和呼吸道合胞病毒的发病率描述

2024-09-281
OAAI
Respiratory Viral Coinfections in Pediatric Patients in the Primary Care Setting: A Multicenter Prospective Study Within the COPEDICAT Network

初级保健环境中儿科患者的呼吸道病毒合并感染: COPEDICAT网络中的一项多中心前瞻性研究

2024-05-280
PRE
Tuberculosis among children visiting friends & relatives
2024-03-041
OAAI
A longitudinal prospective study of active tuberculosis in a Western Europe setting: insights and findings

西欧地区活动性结核病的纵向前瞻性研究: 见解和发现

2024-02-131
OAAI
Clinical standards for drug-susceptible TB in children and adolescents
2023-08-0110
OAAI
Policies on children and schools during the SARS-CoV-2 pandemic in Western Europe

西欧SARS-CoV-2大流行期间的儿童和学校政策

2023-07-2510
OAAI
Multisystem inflammatory syndrome in children and SARS-CoV-2 variants: a two-year ambispective multicentric cohort study in Catalonia, Spain

儿童多系统炎症综合征和SARS-CoV-2变异: 西班牙加泰罗尼亚一项为期两年的ambispective多中心队列研究

2023-02-1818
OAAI